Codexis Inc. diskutieren
Codexis Inc.
WKN: A0Q2S4 / Symbol: CDXS / Name: Codexis / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
2,88 €
1,80 %
Buy Codexis Inc.
Buy beendet
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $6.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $9.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its price target lowered by analysts at Piper Sandler from $14.00 to $10.00. They now have an "overweight" rating on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $9.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $11.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $5.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Codexis, Inc. (NASDAQ: CDXS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $11.00 price target on the stock.
Ratings data for CDXS provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Cheesecake Factory Inc. diskutieren